Giving cancer a taste of its own medicine
James Desmet explores Targeted Protein Degradation, a potential drug discovery strategy capable of treating previously undruggable diseases.
Felix x Women in SET interview Professor Pizza
Imperial professor of microbiology and new co-director of Centre of Bacterial Resistance Biology (CBRB) gives an insight into her journey in vaccine research and development.
New Alzheimer’s drug rejected by NICE
Despite setbacks, the quest for groundbreaking Alzheimer’s treatments continue.
A future with decentralised science
Promoting equity and transparency in scientific research and healthcare data storage.
ICLR celebrate EuRoC success
Felix sits down with ICLR members Andrei Paduraru, Soham More and Pablo Duhamel to discuss the trials and triumphs of launching Nimbus 24
AI to Z: The paradigmatic shift facing the world as we know it
Examining the impacts of AI from industry to intelligence.
Hopfield and Hinton awarded Nobel Prize for shaping the neural network landscape
John Hopfield and Geoffrey Hinton are recognised for their seminal work in artificial neural networks and machine learning.
The tiny molecule that answers a big question
The discovery of microRNA was finally acknowledged in this year’s Nobel Prize in medicine.
Understanding the shape of life
The 2024 Nobel Prize in chemistry was awarded to David Baker, Demis Hassabis, and John Jumper for their protein structure breakthroughs.
Felix interviews Prof Claudia de Rham
Imperial physicist and author sits down with Felix to discuss all things gravity and her life in academia.
Welcome to Felix Science
The team wishes all students and staff members a warm welcome back to Imperial for the brand new academic year.
The insulin controversy in the US: a financial tug-of-war
On the rising prices of insulin in the US and the impact on both companies and patients.